Deepa Shivnani1*, EV Raman1, Shruthi Kobal1, Sathwika1 and Poonam Patil2
1Children’s Airway and Swallowing Center, Department of Otolaryngology and Head and Neck Surgery, Manipal Hospitals, Bangalore, India
2Department of Radiation Oncology, Manipal Hospitals, Bangalore, India
*Corresponding Author: Deepa Shivnani, Children’s Airway and Swallowing Center, Department of Otolaryngology and Head and Neck Surgery, Manipal Hospitals, Bangalore, India.
Received: July 13, 2023; Published: September 06, 2023
Recurrent Respiratory Papillomatosis (RRP) is a benign condition which needs frequent surgical interventions for debulking of papillomatosis lesions for securing the airway. There is no definitive treatment for the management of RRP so far. Bevacizumab either intralesional or systemic has emerged as a promising solution for RRP patients undergoing repeated surgeries. We are reporting a case of a 6-year-old child with juvenile onset RRP who was treated by surgical excision of lesion with adjuvant systemic bevacizumab therapy.
Keyword: Recurrent Respiratory Papillomatosis; JORRP; Medical Treatment; Bevacizumab
Citation: Deepa Shivnani., et al. “Use of Adjuvant Intravenous Bevacizumab for Aggressive Recurrent Respiratory Papillomatosis - A Case Report".Acta Scientific Otolaryngology 5.10 (2023): 07-09.
Copyright: © 2023 Deepa Shivnani., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.